7430
K. Shinhama et al. / Tetrahedron 56 (2000) 7427–7431
ineffective for the conversion of 2 into 4, but did promote
the cyclization from 3a as shown in Table 1.
J6.8 Hz, 2.1H), 0.91 (d, J6.8 Hz, 2.1H), 1.53–1.61 (m,
0.6H), 1.82–2.14 (m, 1H), 2.19 (dt, J4.3, 1.8 Hz, 1.4H),
2.42–2.57 (m, 1.4H), 2.64 (dt, J6.0, 2.2 Hz, 0.6H), 2.72 (t,
J6.0 Hz, 1.4H), 2.87 (dt, J4.5, 2.5 Hz, 0.6H), 3.18–3.33
(m, 1H), 3.43–3.67 (m, 2.4H), 3.81–3.87 (m, 3.6H), 4.05
(dt, J6.0, 2.2 Hz, 0.6H), 4.25 (t, J6.0 Hz, 1.4H), 4.39
(dd, J10.4, 5.0 Hz, 0.7H), 5.20 (dd, J10.0, 4.7 Hz,
0.3H), 6.99–7.17 (m, 3H), and 7.34–7.39 ppm (m, 1H).
Anal. Calcd for C24H29N5O4: C, 63.84; H, 6.47; N, 15.51.
Found: C, 63.82; H, 6.41; N, 15.41.
The subtle assistance of a lithium ion associated with the
steric surroundings of 2 might be key factors involved in this
cyclization reaction, which will be the subject of our further
research.
Summary
In the quest for an efficient synthetic pathway to the dioxy-
genated pyrazines, we developed here a novel thiolate-
mediated ring closure. The key cyclization is triggered by
the deprotection of one CE group by a lithium arylthiolate.
The subsequent cyclization to pyrazine skeleton was
presumably assisted by a lithium cation. Thus, the penulti-
mate intermediate (5) was prepared in a one-pot procedure
by treating the precursor methyl ester (2) with lithium
2-naphthalenethiolate followed by methylation with
dimethyl sulfate in 37% yield. The resulting pyrazinone
(5) was successfully converted to OPC-15161 (1) by the
treatment with sodium hydroxide in DMF–methanol. Our
process research here again revealed the important and
crucial assistance of a protecting group for a new type of
ring closure to inaccessible pyrazinones as well as some
synthetic potential of a thiolate anion for attaining one-pot
process.
N-(2-Cyanoethyl)-N-(2-hydroxyiminoisohexanoyl)-l-tryp-
tophan methyl ester (3a). A mixture of 4N-sodium
hydroxide aq. solution (0.75 ml), 2 (0.45 g, 1.00 mmol),
and THF (20 ml) was stirred at room temperature for 15 h.
After addition of DMF (20 ml) and boric acid (124 mg,
2.01 mmol), the solution was stirred further for 30 min.
Then dimethyl sulfate (0.40 ml, 4.23 mmol) was added to
the solution and stirred further for 2 h. The solution was
diluted with ethyl acetate, washed with saturated aq. sodium
hydrogen sulfate and saturated aq. sodium chloride, dried
over MgSO4, and concentrated. Purification by column
chromatography (silica gel, dichloromethane/methanol
99:1) gave pure 3a (0.26 g, 65%); mp 122–124ЊC. 1H
NMR (CDCl3): 0.73 (m, 1.5H), 0.91 (m, 4.5H), 3.71 (s,
0.75H), 3.76 (s, 2.25H), 4.18 (dd, J10.8 Hz, 0.25H),
6.9–7.4 (m, 4H), 7.56 (d, J8 Hz, 1H), 8.00 (s, 0.75H),
8.90 (s, 0.25H), and 9.41 ppm (s, 0.25H). Anal. Calcd for
C21H26N4O4·0.3H2O: C, 62.44; H, 6.44; N, 13.87. Found: C,
62.43; H, 6.50, N, 13.96.
Experimental
N-(2-Cyanoethyl)-N-(2-hydroxyiminoisohexanoyl)-l-tryp-
tophan benzyl ester (3b). Benzyl ester 3b (2.11 g, 44%)
was obtained from 2 by using benzyl bromide (2 equiv
based on 2) instead of dimethyl sulfate in the same manner
All the melting points were uncorrected. Analytical deter-
minations by HPLC were performed on a Shimadzu LC-6A
liquid chromatography with a TSK gel ODS-80TM column.
1H NMR spectra were taken at Varian 200 MHz spectro-
meter. IR spectra were recorded with a Perkin–Elmer 1600
series FTIR apparatus. Mass spectra were recorded with a
Shimadzu GCMS-QP1000 spectrometer at 70 eV.
1
as in the above experiment. H NMR (CDCl3): 0.68 (d,
J6.4 Hz, 2.4H), 0.85 (d, J6.6 Hz, 3.6H), 1.6–2.3 (m,
5H), 2.5 (m, 1.2H), 2.7 (t, J6 Hz, 0.8H), 3.1–3.8 (m,
4.4H), 4.2 (t, J9 Hz, 0.6H), 5.19 (s, 2H), 7.34 (s, 5H),
6.9–7.4 (m, 4H), 7.58 (d, J10 Hz, 1H), and 8.25 ppm
(br, s, 1H). MS m/z (rel. int.): 474 (Mϩ, 1), 201 (20), and
130 (100). Anal. Calcd for C27H30N4O4: C, 68.34; H, 6.37;
N, 11.81. Found: C, 68.16; H, 6.48, N, 11.64.
Metal thiolates
Metal thiolates used in the following experiments were
prepared from the corresponding thiols by usual methods
(from ArSH and LiOH).5 They were also prepared in situ
by treating thiols with one or more equivalents of anhydrous
lithium hydroxide in dry DMF.
1-(2-Cyanoethyl)-3-isobutyl-5-hydroxy-6-(indol-3-yl)-
methyl-1,2-dihydropyrazin-2-one 4-oxide (4). Method A:
A mixture of 2-mercaptobenzimidazole (6.67 g, 44.4
mmol), anhydrous lithium hydroxide (1.60 g, 66.6 mmol),
and dry DMF (150 ml) was stirred at room temperature for
30 min. After addition of 2 (10.0 g, 22.2 mmol), the mixture
was stirred further for 3 h at room temperature, then diluted
with ethyl acetate (500 ml), and poured into ice-cold hydro-
chloric acid (500 ml). The organic layer was separated,
washed with water, and extracted with aq. sodium hydrogen
carbonate, which was then acidified with hydrochloric acid,
and extracted with ethyl acetate. The organic extract was
washed with water, dried over MgSO4, and concentrated in
vacuo at room temperature to give crude 4 (5.03 g, 62%) as
an unstable yellow amorphous solid. IR (KBr): 3310, 1600,
N-[2-(2-Cyanoethoxyimino)isohexanoyl]-N-(2-cyanoethyl)-
l-tryptophan methyl ester (2). 2-(2-Cyanoethoxyimino)-
isohexanoyl chloride (2.14 kg, 9.88 mol) was added to a
stirred solution of N-(2-cyanoethyl)-l-tryptophan methyl
ester (1.44 kg, 4.72 mol) in dichloromethane (12 l) during
1 h at 27–28ЊC, and the solution was stirred further for
35 min at 22–25ЊC. Then aq. potassium carbonate (2.4 kg
in 3 l of water) was added to the solution. The organic layer
was separated, washed with aq. potassium carbonate, 20%
hydrochloric acid, and saturated aq. sodium chloride, dried
over MgSO4, concentrated, and recrystallized from 60% aq.
i-PrOH to give 2 (1340 g, 63%); mp 102–103ЊC (recrystal-
lized from acetonitrile). IR (neat): 3398, 2961, 2250, 1728,
1
1174, 1099, and 746 cmϪ1. H NMR (CDCl3): 0.97 (d,
J7 Hz, 6H), 2.18–2.40 (m, 1H), 2.48 (t, J6 Hz, 2H),
2.89 (d, J7 Hz, 2H), 3.0–4.0 (br s, 1H), 4.21 (t, J6 Hz,
2H), 4.36 (s, 2H), 7.03–7.63 (m, 5H), and 8.30 ppm (br s,
1
1634, 1435, 1266, 961, and 744 cmϪ1. H NMR (CDCl3):
0.61 (d, J6.8 Hz, 0.9H), 0.65 (d, J6.8 Hz, 0.9H), 0.90 (d,